Lifevantage Overview

  • Status
  • Public

  • Employees
  • 222

Employees

  • Stock Symbol
  • LFVN

Stock Symbol

  • Share Price
  • $13.43
  • (As of Thursday Closing)

Lifevantage General Information

Description

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Contact Information

Formerly Known As
Lifeline Therapeutics, Lifeline Therapeutics, Inc., Yaak River Resources Inc
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 9785 South Monroe Street
  • Suite 300
  • Sandy, UT 84070
  • United States
+1 (866)
Primary Industry
Pharmaceuticals
Other Industries
Beverages
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 9785 South Monroe Street
  • Suite 300
  • Sandy, UT 84070
  • United States
+1 (866)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lifevantage Stock Performance

As of 17-Apr-2025, Lifevantage’s stock price is $13.43. Its current market cap is $169M with 12.6M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.43 $14.19 $5.22 - $27.38 $169M 12.6M 234K $0.60

Lifevantage Financials Summary

As of 31-Dec-2024, Lifevantage has a trailing 12-month revenue of $212M.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 30-Jun-2024 FY 2023 30-Jun-2023 FY 2022 30-Jun-2022
EV 218,334 77,688 49,821 53,535
Revenue 212,152 200,164 213,398 206,360
EBITDA 13,260 7,501 7,380 7,962
Net Income 7,340 2,937 2,540 3,120
Total Assets 68,527 60,299 66,123 70,706
Total Debt 12,769 13,612 13,087 15,755
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lifevantage Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lifevantage‘s full profile, request access.

Request a free trial

Lifevantage Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supp
Pharmaceuticals
Sandy, UT
222 As of 2024

Chesterfield, MO
 

Vaudreuil-Dorion, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lifevantage Competitors (3)

One of Lifevantage’s 3 competitors is Reliv International, a Corporation company based in Chesterfield, MO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Reliv International Corporation Chesterfield, MO
Immunotec Private Equity-Backed Vaudreuil-Dorion, Canada
Garden of Life Canada Corporate Backed or Acquired Richmond Hill, Canada
You’re viewing 3 of 3 competitors. Get the full list »

Lifevantage Patents

Lifevantage Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240398693-A1 Composition and methods for activating cellular signaling genes in innate inflammatory pathways Pending 05-Jun-2023
US-11484563-B2 Compositions and methods for activating cellular signaling pathways Active 13-Jan-2020
US-20210213092-A1 Compositions and methods for activating cellular signaling pathways Active 13-Jan-2020
US-20210213093-A1 Compositions and methods for activating cellular signaling pathways Inactive 13-Jan-2020
US-20210213095-A1 Compositions and methods for activating cellular signaling pathways Inactive 13-Jan-2020 A61K31/198
To view Lifevantage’s complete patent history, request access »

Lifevantage Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lifevantage ESG

Risk Overview

Risk Rating

Updated June, 13, 2021

37.53 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,042

Rank

Percentile

Household Products

Industry

of 104

Rank

Percentile

Personal Products

Subindustry

of 79

Rank

Percentile

To view Lifevantage’s complete esg history, request access »

Lifevantage FAQs

  • Where is Lifevantage headquartered?

    Lifevantage is headquartered in Sandy, UT.

  • What is the size of Lifevantage?

    Lifevantage has 222 total employees.

  • What industry is Lifevantage in?

    Lifevantage’s primary industry is Pharmaceuticals.

  • Is Lifevantage a private or public company?

    Lifevantage is a Public company.

  • What is Lifevantage’s stock symbol?

    The ticker symbol for Lifevantage is LFVN.

  • What is the current stock price of Lifevantage?

    As of 17-Apr-2025 the stock price of Lifevantage is $13.43.

  • What is the current market cap of Lifevantage?

    The current market capitalization of Lifevantage is $169M.

  • What is Lifevantage’s current revenue?

    The trailing twelve month revenue for Lifevantage is $212M.

  • Who are Lifevantage’s competitors?

    Reliv International, Immunotec, and Garden of Life Canada are competitors of Lifevantage.

  • What is Lifevantage’s annual earnings per share (EPS)?

    Lifevantage’s EPS for 12 months was $0.60.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »